Form 4: Senti Bio CEO's Tax-Related Stock Withholding

Senti Biosciences CEO Timothy K Lu reported a tax-related disposition of 4,191 common shares to cover restricted stock unit vesting obligations, not an open market sale.

Summary

• Timothy K Lu, CEO and Director of Senti Biosciences, Inc. (SNTI), reported a transaction on February 2, 2026.
• The transaction involved the disposition of 4,191 shares of common stock.
• These shares were withheld by Senti Biosciences, Inc. to satisfy income tax withholding and remittance obligations related to the net settlement of time-based restricted stock unit awards.
• This transaction was not an open market sale.
• Following the transaction, Timothy K Lu directly beneficially owns 720,249 shares of common stock.
• Additionally, 52,839 shares are indirectly owned by his spouse.
• Another 52,839 shares are indirectly held by Luminen Services, LLC, as trustee of the Luminen Trust, for which Mr. Lu is the settlor, though he disclaims Section 16 beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a standard administrative transaction related to executive compensation and does not indicate any material positive or negative developments for Senti Biosciences.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that tax-related stock withholdings upon the vesting of restricted stock units are a routine and common occurrence for executives receiving equity compensation. This type of transaction is an administrative event and typically does not reflect a change in management's sentiment towards the company's prospects or an intent to sell shares in the open market.

Related Party Transactions

• Timothy K Lu's indirect beneficial ownership includes shares held by his spouse and shares held by Luminen Services, LLC, as trustee of the Luminen Trust, for which Mr. Lu is the settlor. He disclaims Section 16 beneficial ownership of these trust shares except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-open market transaction for tax purposes, not a sale indicating a change in insider sentiment.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related stock withholding for Senti Biosciences' CEO, Timothy K Lu, upon the vesting of restricted stock units. It is not an open market sale and does not provide new information regarding the company's operational performance, financial health, or strategic direction. Therefore, a seasoned investor or institution would likely maintain their current position, as this event does not warrant a change in investment thesis.

Keywords

Senti Biosciences, SNTI, Form 4, Insider Transaction, Stock Withholding, RSU, CEO, Timothy K Lu, Equity Compensation